Category Archives: News and Events

BriaCell Provides Research Update
September 14, 2017

BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 14, 2017 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Provides A Corporate Update
September 12, 2017

Berkeley, CA and Vancouver, BC – September 12, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Additional Capital Support by the CEO
August 2, 2017

Berkeley, CA and Vancouver, BC – Aug 2, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Appoints Top Oncologist and Opens Second Clinical Site for its Ongoing Clinical Trial in Advanced Breast Cancer
July 31, 2017

Berkeley, CA and Vancouver, BC – July 31, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Expands Targeted Pipeline via Acquisition of Sapientia Pharmaceuticals
July 24, 2017

Berkeley, CA and Vancouver, BC – July 24, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Provides Clinical Update on its Ongoing Phase I/IIa Clinical Study of BriaVax™ in Advanced Breast Cancer
July 19, 2017

Berkeley, CA and Vancouver, BC – July 19, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Completes Manufacturing of New Batch of BriaVax™
July 5, 2017

Berkeley, CA and Vancouver, BC – July 5, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Doses Second Patient in Phase I/IIa Clinical Study of BriaVax™ in Advanced Breast Cancer
June 1, 2017

Berkeley, CA and Vancouver, BC – June 1, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Launches Its Scientific Advisory Board
May 31, 2017

Berkeley, CA and Vancouver, BC – May 31, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces First Patient Dosed in Phase I/IIa Clinical Study of BriaVax™ in Advanced Breast Cancer
May 8, 2017

Berkeley, CA and Vancouver, BC – May 8, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

Skip to content